ATE295375T1 - Antikörper und sonstige bindungsmoleküle gegen hepatitis b virusantigene - Google Patents

Antikörper und sonstige bindungsmoleküle gegen hepatitis b virusantigene

Info

Publication number
ATE295375T1
ATE295375T1 AT98937559T AT98937559T ATE295375T1 AT E295375 T1 ATE295375 T1 AT E295375T1 AT 98937559 T AT98937559 T AT 98937559T AT 98937559 T AT98937559 T AT 98937559T AT E295375 T1 ATE295375 T1 AT E295375T1
Authority
AT
Austria
Prior art keywords
hepatitis
antibodies
binding molecules
molecules
binding molecule
Prior art date
Application number
AT98937559T
Other languages
English (en)
Inventor
Wilhelmina Petronella Paulij
Kessel-Koens Marjolijn Jac Van
Original Assignee
Biomerieux Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomerieux Bv filed Critical Biomerieux Bv
Application granted granted Critical
Publication of ATE295375T1 publication Critical patent/ATE295375T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—DNA viruses
    • C07K16/082—Hepadnaviridae (F), e.g. hepatitis B virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/82—Hepatitis associated antigens and antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT98937559T 1997-06-27 1998-06-22 Antikörper und sonstige bindungsmoleküle gegen hepatitis b virusantigene ATE295375T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP97201968 1997-06-27
EP98201458 1998-05-08
PCT/EP1998/004018 WO1999000424A2 (en) 1997-06-27 1998-06-22 Antibodies and other binding molecules specific for hepatitis b viral antigens

Publications (1)

Publication Number Publication Date
ATE295375T1 true ATE295375T1 (de) 2005-05-15

Family

ID=26146644

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98937559T ATE295375T1 (de) 1997-06-27 1998-06-22 Antikörper und sonstige bindungsmoleküle gegen hepatitis b virusantigene

Country Status (7)

Country Link
US (1) US6541198B1 (de)
EP (1) EP0993470B1 (de)
AT (1) ATE295375T1 (de)
AU (1) AU8630898A (de)
DE (1) DE69830174T2 (de)
ES (1) ES2243002T3 (de)
WO (1) WO1999000424A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100419555B1 (ko) * 2000-05-29 2004-02-19 주식회사유한양행 비형간염바이러스의 에스-표면항원을 인식하는단일클론항체의 가변영역 및 이를 코딩하는 유전자
IL143810A (en) 2001-06-18 2008-06-05 Alexander Schoenfeld Prophylactic article useful for both protection and diagnosis and method for use and production thereof
KR100455902B1 (ko) * 2001-07-18 2004-11-12 주식회사 펩트론 Ｂ형 간염 바이러스 표면단백질 프리에스-1 유래의 펩타이드
US8075417B2 (en) * 2008-08-18 2011-12-13 Nike, Inc. Orientation marker for golf club having releasable and interchangeable head and shaft connections
CN109828110A (zh) * 2013-04-26 2019-05-31 生物辐射实验室股份有限公司 多重乙肝试验

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2041772A1 (en) * 1990-05-11 1991-11-12 Larry T. Mimms Monoclonal antibodies to pres2 and pres1 polypeptide of the hepatitis b viral envelope
EP0521348A1 (de) 1991-06-18 1993-01-07 Korea Institute Of Science And Technology Chimerischer Antikörper, spezifisch für das Pre-S2 Oberflächenantigen des Hepatitis-B-Virus und Zellinie, die ihn produziert

Also Published As

Publication number Publication date
WO1999000424A3 (en) 1999-04-22
WO1999000424A2 (en) 1999-01-07
US6541198B1 (en) 2003-04-01
DE69830174D1 (de) 2005-06-16
AU8630898A (en) 1999-01-19
ES2243002T3 (es) 2005-11-16
DE69830174T2 (de) 2006-01-26
EP0993470B1 (de) 2005-05-11
EP0993470A2 (de) 2000-04-19

Similar Documents

Publication Publication Date Title
JP3958796B2 (ja) 抗原特異的ＩｇＧ検出
DK1354204T3 (da) HCV-antigen/antistof-kombinationssay
Gomara et al. Assessment of synthetic peptides for hepatitis A diagnosis using biosensor technology
ATE15274T1 (de) Verfahren und ausruestung zum testen von antikoerpern gegen loesliche antigene.
CA2049679A1 (en) Hepatitis c assay utilizing recombinant antigens
EP0248534A3 (de) Verfahren zum Nachweis einer AIDS-Virus-Infektion
ATE295375T1 (de) Antikörper und sonstige bindungsmoleküle gegen hepatitis b virusantigene
BR0314166B8 (pt) teste de hcv
JP2003202345A (ja) Ｈｃｖコア抗原及び抗体の同時検出試薬
Minenkova et al. ADAM‐HCV, a new‐concept diagnostic assay for antibodies to hepatitis C virus in serum
JP3022954B2 (ja) タイプ特異的抗原を使用する血清学的タイプ分け方法
CA2380777A1 (en) Hepatitis c viral antigen immunoassay detection systems
Sällberg et al. Passive adsorption of immunologically active and inactive synthetic peptides to polystyrene is influenced by the proportion of non-polar residues in the peptide
ES2056041T3 (es) Procedimiento para la deteccion de anticuerpos y antigenos.
TW200722527A (en) Methods of detecting hepatitis C virus
KR970065728A (ko) 합성 펩타이드의 혼합항원을 포함하는 c형 간염 바이러스에 대한 항체의 진단시약
Ireland Development of enzyme-linked immunosorbent assays for antibodies to hepatitis B virus.
Abdukayumov et al. Immuno-enzymatic test system for determination of antibodies to hepatitis C virus in human blood
KR940000871A (ko) 한국형 c형 간염의 진단 방법 및 진단키트
KR950704353A (ko) 씨(c)형 간염 비루스(hcv) 비-구조-3 펩티드, 그에 대한 항체 및 에이취씨브이(hcv)의 검출 방법(hepatitis c virus(hcv) non-structurac-3 peptides, antibodies thereto and methods for the detection of hcv)
CA2116026A1 (en) Hepatitis c assay utilizing recombinant antigens to c-100 region
LI et al. Study on the significance of S/Co ratio of a domestic reagent used for anti-hepatitis C virus antibody detection
AU2004290800A1 (en) Methods and means relating to hepatitis B infection
UA36086A (uk) Тест-система для підтвердження наявності антитіл проти вірусу гепатиту с (іфа-п-hcv)
CA2074370A1 (en) Synthetic antigens for the detection of antibodies to hepatitis c virus

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties